HNGE Fundamental Analysis - HINGE HEALTH INC-A

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to HNGE. HNGE was compared to 100 industry peers in the Health Care Providers & Services industry. HNGE has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, HNGE is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HNGE has reported negative net income.

1.2 Ratios

Looking at the Return On Assets, with a value of -87.87%, HNGE is doing worse than 91.00% of the companies in the same industry.

HNGE's Return On Equity of -165.85% is on the low side compared to the rest of the industry. HNGE is outperformed by 77.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-87.87%
ROE	-165.85%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of HNGE (77.28%) is better than 92.00% of its industry peers.

HNGE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	77.28%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HNGE does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, HNGE has about the same amount of shares outstanding.

HNGE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

HNGE has an Altman-Z score of 3.21. This indicates that HNGE is financially healthy and has little risk of bankruptcy at the moment.

HNGE has a better Altman-Z score (3.21) than 69.00% of its industry peers.

There is no outstanding debt for HNGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	3.21

ROIC/WACCN/A

WACC8.95%

2.3 Liquidity

A Current Ratio of 1.85 indicates that HNGE should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.85, HNGE is in the better half of the industry, outperforming 75.00% of the companies in the same industry.

HNGE has a Quick Ratio of 1.81. This is a normal value and indicates that HNGE is financially healthy and should not expect problems in meeting its short term obligations.

The Quick ratio of HNGE (1.81) is better than 74.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.85
Quick Ratio	1.81

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HNGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.96%, which is quite impressive.

The Revenue has grown by 33.37% in the past year. This is a very strong growth!

EPS 1Y (TTM)88.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)33.37%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, HNGE will show a very strong growth in Earnings Per Share. The EPS will grow by 84.54% on average per year.

HNGE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.99% yearly.

EPS Next Y667.38%

EPS Next 2Y249.78%

EPS Next 3Y142.53%

EPS Next 5Y84.54%

Revenue Next Year49.92%

Revenue Next 2Y35.01%

Revenue Next 3Y28.54%

Revenue Next 5Y24.99%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HNGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

With a Price/Forward Earnings ratio of 30.95, HNGE can be considered very expensive at the moment.

Compared to the rest of the industry, the Price/Forward Earnings ratio of HNGE is on the same level as its industry peers.

HNGE's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.98.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	30.95

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as HNGE's earnings are expected to grow with 142.53% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y249.78%

EPS Next 3Y142.53%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HNGE!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

HINGE HEALTH INC-A

NYSE:HNGE (1/12/2026, 8:04:00 PM)

After market: 48.47 0 (0%)

48.47

+0.55 (+1.15%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)11-04 2025-11-04/bmo

Earnings (Next)N/A N/A

Inst Owners101.65%

Inst Owner Change0.03%

Ins Owners5.33%

Ins Owner Change-14.72%

Market Cap3.82B

Revenue(TTM)807.54M

Net Income(TTM)-676.46M

Analysts82.86

Price Target65.57 (35.28%)

Short Float %12.13%

Short Ratio2.55

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)376.38%

Min EPS beat(2)92.15%

Max EPS beat(2)660.61%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)7.58%

Min Revenue beat(2)6.37%

Max Revenue beat(2)8.79%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)1.47%

EPS NQ rev (1m)4.38%

EPS NQ rev (3m)64.55%

EPS NY rev (1m)5.86%

EPS NY rev (3m)45.9%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)7.25%

Revenue NY rev (1m)0%

Revenue NY rev (3m)4.24%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	30.95
P/S	4.72
P/FCF	N/A
P/OCF	N/A
P/B	9.35
P/tB	11.19
EV/EBITDA	N/A

EPS(TTM)-14.4

EYN/A

EPS(NY)1.57

Fwd EY3.23%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS10.26

BVpS5.18

TBVpS4.33

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-87.87%
ROE	-165.85%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	77.28%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover1.05

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.85
Quick Ratio	1.81
Altman-Z	3.21

F-ScoreN/A

WACC8.95%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)88.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y667.38%

EPS Next 2Y249.78%

EPS Next 3Y142.53%

EPS Next 5Y84.54%

Revenue 1Y (TTM)33.37%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next Year49.92%

Revenue Next 2Y35.01%

Revenue Next 3Y28.54%

Revenue Next 5Y24.99%

EBIT growth 1Y81.28%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year572.84%

EBIT Next 3Y115.55%

EBIT Next 5Y71.84%

FCF growth 1Y166.01%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y176.68%

OCF growth 3YN/A

OCF growth 5YN/A

HINGE HEALTH INC-A / HNGE FAQ

What is the fundamental rating for HNGE stock?

ChartMill assigns a fundamental rating of 4 / 10 to HNGE.

What is the valuation status of HINGE HEALTH INC-A (HNGE) stock?

ChartMill assigns a valuation rating of 2 / 10 to HINGE HEALTH INC-A (HNGE). This can be considered as Overvalued.

What is the profitability of HNGE stock?

HINGE HEALTH INC-A (HNGE) has a profitability rating of 1 / 10.

HINGE HEALTH INC-A (HNGE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

HINGE HEALTH INC-A / HNGE FAQ

What is the fundamental rating for HNGE stock?

What is the valuation status of HINGE HEALTH INC-A (HNGE) stock?

What is the profitability of HNGE stock?